微创脊椎手术设备市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球微创脊椎手术器械市场规模达13.8亿美元，预计2034年将以5.1%的复合年增长率成长，达到22.2亿美元。微创脊椎手术器械因其切口小、住院时间短、恢復期短等优势，日益受到病患的青睐。这些手术疼痛程度较低，且能减少疤痕，因此越来越受到患者的青睐。医学影像和导航技术的进步提高了手术的精确度，有助于提高手术安全性，并使其得到更广泛的应用。

随着微创脊椎手术需求的不断增长，市场在人口老化和脊椎疾病发病率上升的推动下持续增长。在全球老化人口中，退化性椎间盘疾病、椎管狭窄和椎间盘突出等疾病的发生率正在上升，这些疾病通常需要手术介入。此外，久坐不动和身体压力增加等生活型态因素也导致各年龄层脊椎疾病的盛行率上升。随着患者和医护人员逐渐认识到微创技术的优势，例如创伤小、失血少、康復快，人们对此类手术的偏好也日益增长。此外，随着外科技术的进步以及新兴地区高品质医疗机构的普及，患者群体也不断扩大。随着人们对此类手术的认知度不断提高以及医疗覆盖范围的扩大，预计市场将在人口结构变化和医疗创新的共同推动下进一步加速发展。这一趋势凸显了市场对更安全、更有效率的脊椎手术器械的持续需求。

2024年，植入物和器械领域占据71.8%的市场份额，这得益于旨在提高手术精准度和患者康復的先进脊椎固定係统和植入物的日益普及。外科医生更青睐这些器械，因为它们能够增强稳定性、减少术中併发症并促进更快癒合。导航辅助器材、椎间融合器和机器人辅助技术的日益融合也推动了该领域的应用。

2024年，融合手术市场占据66.3%的市场份额，这得益于退化性椎间盘疾病、椎管狭窄症和脊椎滑脱症的盛行率不断上升，这些疾病都需要脊椎稳定。微创融合技术因其能够最大限度地减少组织损伤并加快復健速度，越来越受到患者和外科医生的青睐。融合器械的创新，包括更优的骨移植材料和增强型椎间融合器，显着提高了手术成功率，并扩大了其在门诊和住院环境中的应用。

2024年，北美微创脊椎手术器材市场占据35.3%的市场份额，这得益于其强大的医疗基础设施，鼓励人们迅速采用尖端手术方法和器械。患者和医生对微创手术益处的认知度高，刺激了市场需求。此外，该地区主要医疗器材製造商的集中，促进了持续创新，并确保了产品的广泛供应。

微创脊椎手术设备市场的知名公司包括 Heraeus、Orthofix Medical、Globus Medical、SI-BONE、Invibio、Wenzel Spine、Xenco Medical、Matexcel、Premia Spine、B. Braun、Medtronic、DePuy Synthes（强生）、Spinal Elements、N. Braun、Medtronic、DePuy Synthes（强生）、Spinal Elements、Nvons、Nvonus、Nker、ZM、Mak、Makus、Makaks、Mvonus Spers、Makk、ZM、Mform、Mak Vem、Makk、Misform、Mform、MakMis、Mak Vformings、M完成）微创脊椎手术设备市场的公司透过专注于持续创新并透过先进的植入物、导航工具和机器人辅助解决方案扩展其产品组合来巩固其立足点。与医院和研究机构的策略合作有助于提高设备的功效和外科医生的培训。许多公司在研发方面投入巨资，以开发以患者为中心的解决方案，从而提高手术效果并减少併发症。扩大地域覆盖范围，尤其是进入新兴市场，也是满足不断增长的需求的优先事项。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 脊椎疾病盛行率上升
    • 老年人口不断增加
    • 门诊脊椎手术的采用率增加
    • 导航和机器人技术的进步
  • 产业陷阱与挑战
    • 先进MISS设备成本高
    • 发展中地区缺乏熟练的外科医生
  • 市场机会
    • 与人工智慧和扩增实境的融合
    • 开发具有成本效益的MISS解决方案
• 成长潜力分析
• 监管格局
• 技术和创新格局
  • 当前的技术趋势
  • 新兴技术
• 供应链分析
• 消费者行为趋势
• 市场进入策略分析
• 波特的分析
• PESTEL分析
• 未来市场趋势
• 差距分析
• 2024年定价分析
• 专利态势
• 报销场景
  • 报销政策对市场成长的影响

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 全球的
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：依产品类型，2021 - 2034 年

• 主要趋势
• 植入物和仪器
  • 椎弓根螺钉和椎弓根棒
  • 椎间融合器
  • 固定係统
  • 其他植入物和器械
• 生物材料
  • 骨移植替代品
  • 合成骨移植
  • 其他生物材料

第六章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 融合手术
• 非融合手术

第七章：市场估计与预测：按适应症，2021 - 2034 年

• 主要趋势
• 腰椎间盘突出
• 椎管狭窄
• 退化性脊椎疾病
• 颈椎间盘疾病
• 胸椎间盘突出
• 其他适应症

第八章：市场估计与预测：依最终用途，2021 - 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第九章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：公司简介

• B. Braun
• DePuy Synthes (Johnson & Johnson)
• Evonik
• Globus Medical
• Heraeus
• Invibio
• Matexcel
• Medtronic
• Nexus Spine
• NuVasive
• Orthofix Medical
• Premia Spine
• SI-BONE
• Spinal Elements
• Stryker
• Wenzel Spine
• Xenco Medical
• Zimmer Biomet

The Global Minimally Invasive Spine Surgery Devices Market was valued at USD 1.38 billion in 2024 and is estimated to grow at a CAGR of 5.1% to reach USD 2.22 billion by 2034. The growing preference for minimally invasive spine surgery devices is fueled by the advantages of smaller incisions, shorter hospital stays, and quicker recovery periods. These procedures are less painful and reduce scarring, making them increasingly favored by patients. Advances in medical imaging and navigation technology have enhanced surgical accuracy, contributing to safer procedures and wider adoption.

As demand for minimally invasive spinal surgeries increases, the market continues to grow, supported by an aging population and rising spinal disorders. Aging populations worldwide are experiencing higher incidences of conditions like degenerative disc disease, spinal stenosis, and herniated discs, which often require surgical intervention. Additionally, lifestyle factors such as sedentary habits and increased physical strain contribute to the prevalence of spinal issues across all age groups. With patients and healthcare providers recognizing the benefits of minimally invasive techniques-such as reduced trauma, less blood loss, and quicker rehabilitation-the preference for these procedures is steadily climbing. Furthermore, advancements in surgical technology and growing access to high-quality healthcare facilities in emerging regions are broadening the patient base. As awareness improves and insurance coverage expands for these procedures, the market is expected to accelerate further, driven by both demographic shifts and medical innovations. This trend underscores a sustained demand for devices that facilitate safer, more efficient spinal surgeries.

In 2024, implants and instrumentation segment accounted for 71.8% share, driven by the increasing use of advanced spinal fixation systems and implants designed to improve surgical precision and patient recovery. Surgeons prefer these devices due to their ability to enhance stability, reduce intraoperative complications, and support quicker healing. The growing integration of navigation-assisted instruments, interbody cages, and robotic-assisted technologies is also boosting the adoption of this segment.

The fusion surgery segment held 66.3% share in 2024, propelled by the rising prevalence of degenerative disc diseases, spinal stenosis, and spondylolisthesis, which require spinal stabilization. Minimally invasive fusion techniques are gaining popularity among patients and surgeons alike because they minimize tissue damage and accelerate recovery. Innovations in fusion devices, including better bone graft materials and enhanced interbody cages, have significantly improved surgical success rates and broadened their use across outpatient and hospital environments.

North America Minimally Invasive Spine Surgery Devices Market held 35.3% share in 2024, owing to its robust healthcare infrastructure that encourages swift adoption of cutting-edge surgical methods and devices. High patient and physician awareness regarding the benefits of minimally invasive procedures fuels demand. Furthermore, the region's concentration of key medical device manufacturers fosters ongoing innovation and ensures wide product availability.

Notable companies operating in the Minimally Invasive Spine Surgery Devices Market include Heraeus, Orthofix Medical, Globus Medical, SI-BONE, Invibio, Wenzel Spine, Xenco Medical, Matexcel, Premia Spine, B. Braun, Medtronic, DePuy Synthes (Johnson & Johnson), Spinal Elements, Nexus Spine, Stryker, Zimmer Biomet, NuVasive, and Evonik. Companies in the Minimally Invasive Spine Surgery Devices Market strengthen their foothold by focusing on continuous innovation and expanding their product portfolios with advanced implants, navigation tools, and robotic-assisted solutions. Strategic collaborations with hospitals and research institutions help improve device efficacy and surgeon training. Many firms invest heavily in R&D to develop patient-centric solutions that enhance surgical outcomes and reduce complications. Expanding geographic reach, particularly into emerging markets, is also a priority to tap into growing demand.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 Indication trends
  • 2.2.5 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of spine disorders
    • 3.2.1.2 Growing geriatric population
    • 3.2.1.3 Increased adoption of outpatient spine surgeries
    • 3.2.1.4 Technological advancements in navigation and robotics
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced MISS equipment
    • 3.2.2.2 Lack of skilled surgeons in developing regions
  • 3.2.3 Market opportunities
    • 3.2.3.1 Integration with AI and augmented reality
    • 3.2.3.2 Development of cost-effective MISS solutions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Supply chain analysis
• 3.7 Consumer behaviour trend
• 3.8 Go-to-market strategy analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis
• 3.11 Future market trends
• 3.12 Gap analysis
• 3.13 Pricing analysis, 2024
• 3.14 Patent Landscape
• 3.15 Reimbursement scenario
  • 3.15.1 Impact of reimbursement policies on market growth

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
  • 4.2.5 Latin America
  • 4.2.6 Middle East and Africa
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Implants and instrumentation
  • 5.2.1 Pedicle screws and rods
  • 5.2.2 Interbody cages
  • 5.2.3 Fixation systems
  • 5.2.4 Other implants and instrumentations
• 5.3 Biomaterials
  • 5.3.1 Bone graft substitutes
  • 5.3.2 Synthetic bone grafts
  • 5.3.3 Other biomaterials

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Fusion surgery
• 6.3 Non-fusion surgery

Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Lumbar disc herniation
• 7.3 Spinal stenosis
• 7.4 Degenerative spinal disease
• 7.5 Cervical disc disorders
• 7.6 Thoracic disc herniation
• 7.7 Other indications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 B. Braun
• 10.2 DePuy Synthes (Johnson & Johnson)
• 10.3 Evonik
• 10.4 Globus Medical
• 10.5 Heraeus
• 10.6 Invibio
• 10.7 Matexcel
• 10.8 Medtronic
• 10.9 Nexus Spine
• 10.10 NuVasive
• 10.11 Orthofix Medical
• 10.12 Premia Spine
• 10.13 SI-BONE
• 10.14 Spinal Elements
• 10.15 Stryker
• 10.16 Wenzel Spine
• 10.17 Xenco Medical
• 10.18 Zimmer Biomet